Business Context and Reporting Period
This Form 8-K is a current report filed by Adherex Technologies Inc. (not Fennec Pharmaceuticals Inc. as indicated in the metadata) on June 15, 2012. The filing reports on the results of the Company's annual meeting of shareholders held on June 12, 2012.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance report regarding shareholder votes and does not contain financial performance data.
Material Changes
No material financial changes are reported. The filing details the successful election of the Board of Directors and the re-appointment of the independent public accounting firm.
Guidance, Outlook, and Management Commentary
The filing contains no guidance, outlook, or management commentary regarding future operations. It strictly reports the voting outcomes of the annual meeting.
Shareholder Vote Results
- Director Elections: All five nominees were elected with 22,994,176 votes "For" and 1,216 votes "Withheld" for each candidate.
- Accounting Firm: The resolution to re-appoint Deloitte & Touche LLP was approved with 25,139,215 votes "For", 166 votes "Withheld", and 22 abstentions.
Important Facts for Investor Verification
- Verify the registrant name is Adherex Technologies Inc., not Fennec Pharmaceuticals Inc.
- Confirm the election of the five directors: Robert C. Andrade, David Lieberman, Chris Rallis, Rostislav Raykov, and Steven Skolsky.
- Note the re-appointment of Deloitte & Touche LLP as the independent auditor.
- Understand that this filing contains no financial statements or operational metrics.